Skip to main content


  • J. L. SIMPSON (a1) and M. G. ROBERTS (a2)

A nation-wide vaccination campaign began in New Zealand in 2004 with the aim of stopping the epidemic of meningococcal B disease. Approximately 80% of those under 20 years of age when the campaign was launched were vaccinated with three doses of a tailor-made vaccine. We propose a framework for a mathematical model based on the susceptible–carrier–infectious–removed (SCIR) structure. We show how the model could be used to calculate the predicted yearly incidence of infection in the absence of vaccination, and compare this to the effect that vaccination had on the course of the epidemic. Our model shows that vaccination led to a considerable decrease in the incidence of infection compared to what would have been seen otherwise. We then use our model to explore the potential effect of alternative vaccination schemes, and show that the one that was implemented was the best of all the possibilities we consider.

Corresponding author
Hide All
[1]Ancel, L. W., Levin, B. R., Richardson, A. R. and Stojiljkovic, I., “Two-tiered evolution of Neisserria meningitidis: how within-host ecology and between-host epidemiology expedite phase shifting”, 2001, Santa Fe Institute working paper;
[2]Ancel Meyers, L., Levin, B. R., Richardson, A. R. and Stojiljkovic, I., “Epidemiology, hypermutation, within-host evolution and the virulence of Neisseria meningitidis”, Proc. R. Soc. Lond. B 270 (2003) 16671677; doi:10.1098/rspb.2003.2416.
[3]Baker, M., McNicholas, A., Garrett, N., Jones, N., Stewart, J., Koberstein, V. and Lennon, D., “Household crowding a major risk factor for epidemic meningococcal disease in Auckland children”, Paediatric Infect. Dis. J. 19 (2000) 983990; doi:10.1097/00006454-200010000-00009.
[4]Cartwright, K., Meningococcal disease (John Wiley & Sons, Chichester, 1995).
[5]CBG Health Research, “Evaluation of meningococcal B immunisation national roll out – final report, prepared for the Ministry of Health”, 2006;
[6]Coen, P. G., Cartwright, K. and Stuart, J., “Mathematical modelling of infection and disease due to Neisseria meningitidis and Neisseria lactamica”, Int. J. Epidemiol. 29 (2000) 180188; doi:10.1093/ije/29.1.180.
[7]Diekmann, O. and Heesterbeek, J. A. P., Mathematical epidemiology of infectious diseases: model building, analysis and interpretation (John Wiley & Sons, Chichester, 2000).
[8]Environmental Science and Research Limited, “The epidemiology of meningococcal disease in New Zealand in 2006”, Ministry of Health, Wellington, 2006,
[9]Guinea, F., Jansen, V. A. A. and Stollenwerk, N., “Statistics of infections with diversity in the pathogenicity”, Biophys. Chem. 115 (2005) 181185; doi:10.1016/j.bpc.2004.12.024.
[10]Kelly, C., Arnold, R., Galloway, Y. and O’Hallahan, J., “A prospective study of the effectiveness of the New Zealand meningococcal B vaccine”, Am. J. Epidemiol. 166 (2007) 817823; doi:10.1093/aje/kwm147.
[11]Mann, J., “Modelling infectious disease epidemiology and vaccination impact”, Ph. D. Thesis, Massey University, 2009;
[12]Martcheva, M. and Crispino-O’Connell, G., “The transmission of meningococcal infection: a mathematical study”, J. Math. Anal. Appl. 283 (2003) 251275; doi:10.1016/S0022-247X(03)00289-0.
[13]Ministry of Health, Immunisation Handbook 2011, (Ministry of Health, Wellington, 2011),
[14]Ministry of Health, “Meningococcal disease: fact sheet 1”, Ministry of Health, Wellington, 2004,
[15]Roberts, M. G. and Tobias, M. I., “Predicting and preventing measles epidemics in New Zealand: application of a mathematical model”, Epidemiol. Infect. 124 (2000) 279287; doi:10.1017/S0950268899003556.
[16]Stollenwerk, N. and Jansen, V. A. A., “Evolution towards criticality in an epidemiological model for meningococcal disease”, Phys. Lett. A 317 (2003) 8796; doi:10.1016/j.physleta.2003.08.017.
[17]Stollenwerk, N. and Jansen, V. A. A., “Meningitis, pathogenicity near criticality: the epidemiology of meningococcal disease as a model for accidental pathogens”, J. Theor. Biol. 222 (2003) 347359; doi:10.1016/S0022-5193(03)00041-9.
[18]Stollenwerk, N., Maiden, M. C. J. and Jansen, V. A. A., “Diversity in pathogenicity can cause outbreaks of meningococcal disease”, Proc. Natl. Acad. Sci. 101 (2004) 10 22910 234; doi:10.1073/pnas.0400695101.
[19]Thomas, M., “Prevention of group B meningococcal disease by vaccination: a difficult task”, New Zealand Medical J. 117 (2004) 2131;
[20]Trotter, C. L., Edmunds, W. J., Ramsay, M. E. and Miller, E., “Modelling future changes to the meningococcal serogroup C conjugate (MCC) vaccine program in England and Wales”, Human Vaccines 2 (2006) 6873; doi:10.4161/hv.2.2.2611.
[21]Trotter, C. L. and Gay, N. J., “Analysis of longitudinal bacterial carriage studies accounting for sensitivity of swabbing: an application to Neiseria meningitidis”, Epidemiol. Infect. 130 (2003) 201205; doi:10.1017/S0950268802008130.
[22]Trotter, C. L., Gay, N. J. and Edmunds, W. J., “Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination”, Am. J. Epidemiol. 162 (2005) 89100; doi:10.1093/aje/kwi160.
[23]Tuckwell, H. C., Hanslik, T., Valleron, A.-J. and Flahault, A., “A mathematical model for evaluating the impact of vaccination schedules: application to Neisseria meningitidis”, Epidemiol. Infect. 130 (2003) 419429; doi:10.1017/S0950268803008501.
[24]Tyski, S., Grzybowska, W., Dulny, G., Berthelsen, L. and Lind, I., “Phenotypical and genotypical characterization of Neisseria meningitidis carrier strains isolated from Polish recruits in 1998”, Euro. J. Clin. Microbiol. Infect. Dis. 20 (2001) 350353; doi:10.1007/PL00011275.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

The ANZIAM Journal
  • ISSN: 1446-1811
  • EISSN: 1446-8735
  • URL: /core/journals/anziam-journal
Please enter your name
Please enter a valid email address
Who would you like to send this to? *


MSC classification


Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed